Vanda Pharmaceuticals
VNDA
#7486
Rank
C$0.59 B
Marketcap
C$10.07
Share price
2.23%
Change (1 day)
65.54%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -C$0.17 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are C$0.21 Billion. In 2024 the company made an earning of -C$55.96 Million a decrease over its 2023 earnings that were of -C$19.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.17 Billion203.34%
2024 -C$55.96 Million191.43%
2023 -C$19.21 Million-320.45%
2022 C$8.7 M-84.99%
2021 C$58.02 M54.8%
2020 C$37.48 M19.42%
2019 C$31.39 M4.93%
2018 C$29.91 M-228.6%
2017 -C$23.27 Million-8.98%
2016 -C$25.56 Million-53.79%
2015 -C$55.31 Million-30.18%
2014 -C$79.21 Million173.08%
2013 -C$29.01 Million-25.33%
2012 -C$38.85 Million163.61%
2011 -C$14.74 Million-221.15%
2010 C$12.16 M-124.53%
2009 -C$49.59 Million-29.44%
2008 -C$70.28 Million-36.2%
2007 -C$0.12 Billion21.81%
2006 -C$90.43 Million170.55%
2005 -C$33.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$46.17 B-27,807.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.50 B-13,603.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$14.02 B-8,516.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$35.41 B-21,348.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$30.85 B-18,617.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$12.83 B-7,803.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-C$3.87 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA